Kraig Biocraft Deploys Over 700,000 Spider Silk Hybrids

Milestone achievement in the company's aggressive production expansion plan.

Mar. 30, 2026 at 11:28am

Got story updates? Submit your updates here. ›

Kraig Biocraft Laboratories, a leader in spider silk technology, has successfully deployed more than 700,000 BAM-1 Alpha production hybrids, a key milestone in the company's plan to dramatically increase recombinant spider silk output to metric ton levels.

Why it matters

Kraig's ability to rapidly scale up production of its engineered spider silk materials is crucial to the company's long-term commercial success and the potential widespread adoption of this innovative biomaterial in the global textile industry.

The details

The deployment of over 700,000 BAM-1 Alpha hybrids, out of a 1 million egg inventory, represents a major step forward in Kraig's aggressive expansion strategy. The company's production team has reported that the new hybrids are performing exceptionally well, exceeding internal expectations for robustness and productivity.

  • Kraig Biocraft Laboratories announced the deployment in March 2026.
  • In February 2026, the company outlined its plan for rapid production expansion.

The players

Kraig Biocraft Laboratories

A reporting biotechnology company and the leading developer of genetically engineered spider silk-based fiber technologies.

Kim Thompson

Founder and CEO of Kraig Biocraft Laboratories.

Got photos? Submit your photos here. ›

What they’re saying

“This is exactly the kind of disciplined, structured, and milestone-driven execution we set out to achieve. We laid out an ambitious plan to scale production to unprecedented levels, and we are now systematically delivering against that roadmap.”

— Kim Thompson, Founder and CEO

“We see these results as a clear demonstration that our strategy is working. We are executing an aggressive plan, hitting our milestones, and moving with purpose toward industrial-scale commercial spider silk production.”

— Kim Thompson, Founder and CEO

What’s next

Kraig Biocraft Laboratories is continuing to advance toward its goal of producing spider silk at metric ton levels, with the successful deployment of this latest production run positioning the company to achieve this target on an accelerated timeline.

The takeaway

Kraig Biocraft Laboratories' ability to rapidly scale up production of its engineered spider silk materials is a crucial milestone in the company's long-term commercial success and the potential widespread adoption of this innovative biomaterial in the global textile industry.